Moberg Pharma AB (Moberg Pharma AB) Total Assets : $60.71 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Moberg Pharma AB Total Assets?

Moberg Pharma AB's Total Assets for the quarter that ended in Mar. 2024 was $60.71 Mil.

During the past 12 months, Moberg Pharma AB's average Total Assets Growth Rate was 27.10% per year.

During the past 13 years, Moberg Pharma AB's highest 3-Year average Total Assets Growth Rate was 367.90%. The lowest was -31.90%. And the median was 61.15%.

Total Assets is connected with ROA %. Moberg Pharma AB's annualized ROA % for the quarter that ended in Mar. 2024 was -4.07%. Total Assets is also linked to Revenue through Asset Turnover. Moberg Pharma AB's Asset Turnover for the quarter that ended in Mar. 2024 was 0.00.

Moberg Pharma AB Total Assets Historical Data

The historical data trend for Moberg Pharma AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB Total Assets Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

138.60

49.61

54.39

61.88

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															52.62	51.05	58.11	61.88	60.71

Moberg Pharma AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Moberg Pharma AB's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	59.539	+	2.34
	=	61.88

Moberg Pharma AB's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	58.095	+	2.611
	=	60.71

Moberg Pharma AB (OTCPK:MBGPF) Total Assets Explanation

Total Assets is connected with ROA %.

Moberg Pharma AB's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-2.496	/	( (61.879	+	60.706)	/ 2 )
	=	-2.496	/	61.2925
	=	-4.07 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Moberg Pharma AB's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	0.079	/	( (61.879	+	60.706)	/ 2 )
=	0.079	/	61.2925
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Moberg Pharma AB Total Assets Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (Moberg Pharma AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OTCPK:MBGPF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

MOB:Sweden MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.